Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;19(4):525-534.
doi: 10.1007/s10388-022-00933-6. Epub 2022 Jun 29.

Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease

Pierfrancesco Visaggi  1 , Lucia Mariani  1 , Federica Baiano Svizzero  1 , Luca Tarducci  1 , Andrea Sostilio  1 , Marzio Frazzoni  2 , Salvatore Tolone  3 , Roberto Penagini  4   5 , Leonardo Frazzoni  6 , Linda Ceccarelli  1 , Vincenzo Savarino  7 , Massimo Bellini  1 , Prakash C Gyawali  8 , Edoardo V Savarino  9 , Nicola de Bortoli  10
Affiliations
Review

Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease

Pierfrancesco Visaggi et al. Esophagus. 2022 Oct.

Abstract

The clinical diagnosis of gastro-esophageal reflux disease (GERD) is based on the presence of typical esophageal troublesome symptoms. In clinical practice, heartburn relief following a proton pump inhibitor (PPI) trial or endoscopy can confirm a diagnosis of GERD. In cases of diagnostic uncertainty or before anti-reflux interventions, combined impedance-pH monitoring (MII-pH) provides a comprehensive assessment of both physical and chemical properties of the refluxate, allowing to achieve a conclusive diagnosis of GERD. Recently, the Lyon Consensus proposed the use of mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave index (PSPW-I) as novel MII-pH metrics to support the diagnosis of GERD. The calculation of MNBI and PSPW-I currently needs to be performed manually, but artificial intelligence systems for the automated analysis of MII-pH tracings are being developed. Several studies demonstrated the increased diagnostic yield MNBI and PSPW-I for the categorization of patients with GERD at both on- and off-PPI MII-pH monitoring. Accordingly, we performed a narrative review on the clinical use and diagnostic yield of MNBI and PSPW-I when the diagnosis of GERD is uncertain. Based on currently available evidence, we strongly support the evaluation of PSPW-I and MNBI as part of the standard assessment of MII-pH tracings for the evaluation of GERD, especially in patients with endoscopy-negative heartburn.

Keywords: Diagnosis; GERD; MNBI; PSPW index; Reflux disease.

PubMed Disclaimer

Conflict of interest statement

Pierfrancesco Visaggi: None; Lucia Mariani: None; Federica Baiano Svizzero: None; Luca Tarducci: None; Andrea Sostilio: None; Marzio Frazzoni: None; Salvatore Tolone: None; Roberto Penagini: received Lecture Fee: Alfasigma, Reckitt Benckiser, Sofar, Leonardo Frazzoni: None, Linda Ceccarelli: None; Vincenzo Savarino: received lecture fees from Reckitt Benkiser, Takeda, Grunenthal, Teofarma, Alfasigma; Massimo Bellini: None, Prakash C Gyawali: None, Edoardo V. Savarino: received lecture fees from Abbvie, Alfasigma, Amgen, Aurora Pharma, Bristol-Myers Squibb, EG Stada Group, Fresenius Kabi, Grifols, Janssen, Johnson&Johnson, Innovamedica, Malesci, Medtronic, Merck & Co, Reckitt Benckiser, Sandoz, Shire, SILA, Sofar, Takeda, Unifarco, Nicola de Bortoli: received lecture fees from Malesci and Reckitt Benckiser.

Figures

Fig. 1
Fig. 1
A 10-min window used to calculate the mean nocturnal baseline impedance at multichannel intraluminal pH-impedance monitoring
Fig. 2
Fig. 2
a Post-reflux swallow-induced peristaltic wave within 30 s after a reflux. This peristaltic wave should be included when calculating the PSPW index. b A peristaltic wave taking place 45 s after a reflux. This peristaltic wave should not be included when calculating the PSPW index
See this image and copyright information in PMC

References

    1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920. - PubMed
    1. Visaggi P, Barberio B, Ghisa M, et al. Modern diagnosis of early esophageal cancer: from blood biomarkers to advanced endoscopy and artificial intelligence. Cancers. 2021;13:3162. - PMC - PubMed
    1. Chiocca JC, Olmos JA, Salis GB, et al. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther. 2005;22:331–342. - PubMed
    1. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si. Korea Am J Gastroenterol. 2005;100:747–753. - PubMed
    1. Locke GR, 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456. - PubMed

Publication types

Substances

LinkOut - more resources